APA

Burmeister B. H., Henderson M. A., Ainslie J., Fisher R., Di Iulio J., Smithers B. M., Hong A., Shannon K., Scolyer R. A., Carruthers S., Coventry B. J., Babington S., Duprat J., Hoekstra H. J. & Thompson J. F. (20120815). Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. : The Lancet. Oncology.

Chicago

Burmeister Bryan H, Henderson Michael A, Ainslie Jill, Fisher Richard, Di Iulio Juliana, Smithers B Mark, Hong Angela, Shannon Kerwin, Scolyer Richard A, Carruthers Scott, Coventry Brendon J, Babington Scott, Duprat Joao, Hoekstra Harald J and Thompson John F. 20120815. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. : The Lancet. Oncology.

Harvard

Burmeister B. H., Henderson M. A., Ainslie J., Fisher R., Di Iulio J., Smithers B. M., Hong A., Shannon K., Scolyer R. A., Carruthers S., Coventry B. J., Babington S., Duprat J., Hoekstra H. J. and Thompson J. F. (20120815). Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. : The Lancet. Oncology.

MLA

Burmeister Bryan H, Henderson Michael A, Ainslie Jill, Fisher Richard, Di Iulio Juliana, Smithers B Mark, Hong Angela, Shannon Kerwin, Scolyer Richard A, Carruthers Scott, Coventry Brendon J, Babington Scott, Duprat Joao, Hoekstra Harald J and Thompson John F. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. : The Lancet. Oncology. 20120815.